Agios Announces the Phase 3 ACTIVATE Trial of Mitapivat Achieved Its Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused Read more about Agios Announces the Phase 3 ACTIVATE Trial of Mitapivat Achieved Its Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
Agios Launches Anemia ID, a No-Cost Genetic Testing Program for Hereditary Anemias Read more about Agios Launches Anemia ID, a No-Cost Genetic Testing Program for Hereditary Anemias
Agios at Piper Sandler 32nd Annual Virtual Healthcare Conference Read more about Agios at Piper Sandler 32nd Annual Virtual Healthcare Conference
Agios to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020 Read more about Agios to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease Read more about Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
Agios Reports Business Highlights and Third Quarter 2020 Financial Results Read more about Agios Reports Business Highlights and Third Quarter 2020 Financial Results
Agios to Present Broad Set of Clinical and Translational Data for Oncology and Rare Genetic Disease Programs at the Virtual 2020 ASH Annual Meeting Read more about Agios to Present Broad Set of Clinical and Translational Data for Oncology and Rare Genetic Disease Programs at the Virtual 2020 ASH Annual Meeting
Agios to Host a Webinar on its Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook on Thursday, November 19, 2020 Read more about Agios to Host a Webinar on its Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook on Thursday, November 19, 2020
Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020 Read more about Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020